230 related articles for article (PubMed ID: 6862927)
1. Dose-response relationships for bone cancers from plutonium in dogs and people.
Muggenburg BA; Mewhinney JA; Griffith WC; Hahn FF; McClellan RO; Boecker BB; Scott BR
Health Phys; 1983; 44 Suppl 1():529-35. PubMed ID: 6862927
[TBL] [Abstract][Full Text] [Related]
2. Primary bone neoplasms in beagle dogs exposed by inhalation to aerosols of plutonium-238 dioxide.
Hahn FF; Mewhinney JA; Merickel BS; Guilmette RA; Boecker BB; McClellan RO
J Natl Cancer Inst; 1981 Oct; 67(4):917-27. PubMed ID: 6944558
[TBL] [Abstract][Full Text] [Related]
3. Bone tumors induced by inhalation of 238PuO2 in dogs.
Park JF; Lund JE; Ragan HA; Hackett PL; Frazier ME
Recent Results Cancer Res; 1976; (54):17-35. PubMed ID: 1070720
[TBL] [Abstract][Full Text] [Related]
4. Sites of incidence of osteosarcoma in the long bones of man and the beagle.
Spiers FW; Beddoe AH
Health Phys; 1983; 44 Suppl 1():49-64. PubMed ID: 6575001
[TBL] [Abstract][Full Text] [Related]
5. Quantitative comparisons of cancer induction in humans by internally deposited radionuclides and external radiation.
Harrison JD; Muirhead CR
Int J Radiat Biol; 2003 Jan; 79(1):1-13. PubMed ID: 12556326
[TBL] [Abstract][Full Text] [Related]
6. Toxicity of inhaled plutonium dioxide in beagle dogs.
Muggenburg BA; Guilmette RA; Mewhinney JA; Gillett NA; Mauderly JL; Griffith WC; Diel JH; Scott BR; Hahn FF; Boecker BB
Radiat Res; 1996 Mar; 145(3):361-81. PubMed ID: 8927705
[TBL] [Abstract][Full Text] [Related]
7. The influence of age at time of exposure to 226Ra or 239Pu on distribution, retention, postinjection survival, and tumor induction in beagle dogs.
Bruenger FW; Lloyd RD; Miller SC
Radiat Res; 1991 Mar; 125(3):248-56. PubMed ID: 2000447
[TBL] [Abstract][Full Text] [Related]
8. Risks of fatal cancer from inhalation of 239,240plutonium by humans: a combined four-method approach with uncertainty evaluation.
Grogan HA; Sinclair WK; Voillequé PG
Health Phys; 2001 May; 80(5):447-61. PubMed ID: 11316075
[TBL] [Abstract][Full Text] [Related]
9. Lung fibrosis and lung cancer incidence in beagle dogs that inhaled 238PuO2 or 239PuO2.
Wilson DA; Diel JH; Hoel DG
Health Phys; 2009 Apr; 96(4):493-503. PubMed ID: 19280755
[TBL] [Abstract][Full Text] [Related]
10. Relationship of natural incidence and radiosensitivity for bone cancer in dogs.
Taylor GN; Lloyd RD; Mays CW; Miller SC; Jee WS; Mori S; Shabestari L; Li XJ
Health Phys; 1997 Oct; 73(4):679-83. PubMed ID: 9314230
[TBL] [Abstract][Full Text] [Related]
11. Review of 239Pu and 226Ra effects in beagles.
Lloyd RD; Taylor GN; Miller SC; Bruenger FW; Jee WS
Health Phys; 2001 Dec; 81(6):691-7. PubMed ID: 11725888
[TBL] [Abstract][Full Text] [Related]
12. Relative radiosensitivity of bone tumor induction among beagles as a function of age at injection of 239Pu or 226Ra.
Lloyd RD; Taylor GN; Jee WS; Miller SC
Health Phys; 1999 Jan; 76(1):50-6. PubMed ID: 9883947
[TBL] [Abstract][Full Text] [Related]
13. Mechanistic models of bone cancer induction by radium and plutonium in animals compared to humans.
Bijwaard H
Radiat Prot Dosimetry; 2006; 122(1-4):340-4. PubMed ID: 17166879
[TBL] [Abstract][Full Text] [Related]
14. Osteosarcomas among beagles exposed to 239Pu.
Whittemore AS; McMillan A
Radiat Res; 1982 Apr; 90(1):41-56. PubMed ID: 6950452
[No Abstract] [Full Text] [Related]
15. Bone cancer occurrence among beagles given 239Pu as young adults.
Lloyd RD; Taylor GN; Angus W; Bruenger FW; Miller SC
Health Phys; 1993 Jan; 64(1):45-51. PubMed ID: 8416214
[TBL] [Abstract][Full Text] [Related]
16. Cancer incidence and lifespan vs. alpha-particle dose in beagles.
Mays CW; Lloyd RD; Taylor GN; Wrenn ME
Health Phys; 1987 May; 52(5):617-24. PubMed ID: 3570798
[TBL] [Abstract][Full Text] [Related]
17. Lung fibrosis and lung cancer incidence in beagle dogs that inhaled 238PuO2 or 239PuO2.
Wilson D
Health Phys; 2009 Feb; 96(2):175-85. PubMed ID: 19131739
[TBL] [Abstract][Full Text] [Related]
18. Comparisons of the skeletal locations of putative plutonium-induced osteosarcomas in humans with those in beagle dogs and with naturally occurring tumors in both species.
Miller SC; Lloyd RD; Bruenger FW; Krahenbuhl MP; Polig E; Romanov SA
Radiat Res; 2003 Nov; 160(5):517-23. PubMed ID: 14565831
[TBL] [Abstract][Full Text] [Related]
19. Effective thresholds for induction of skeletal malignancies by radionuclides.
Lloyd RD; Taylor GN; Fisher DR; Schlenker RA; Miller SC
Health Phys; 2000 Dec; 79(6):722-7. PubMed ID: 11089810
[TBL] [Abstract][Full Text] [Related]
20. Scaling of fatal cancer risks from laboratory animals to man.
Raabe OG
Health Phys; 1989; 57 Suppl 1():419-32. PubMed ID: 2606702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
